Dnsgvtissue
About
What does Dnsgvtissue do?
Dnsgvtissue is developing an AI-driven platform designed to revolutionize tissue analysis and diagnostics. Their technology aims to provide faster, more accurate insights from histopathology data, assisting researchers and clinicians in disease detection and treatment planning.
What industry does Dnsgvtissue operate in?
Dnsgvtissue operates in HealthTech, MedTech, Biotech, AI-Driven Protein Design, Drug Discovery, Clinical Trials.
What is Dnsgvtissue's current status?
Dnsgvtissue's current operating status is: Inactive.
Clinical Trial Discovery by ENSCORE.
Medbytes provides doctors with a personalized platform for high-impact medical research and news in their specialty.
An independent research reference providing accessible, accurate, and transparent information on bioactive peptides and peptide science.
SYLARIS™ offers premium wearable wellness patches and clinical-grade skincare designed for effortless, intentional, and beautifully designed self-care rituals.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
Purpose-built WordPress plugins for healthcare and the agencies that serve them.
AI-powered platform for medspas to automate client retention and marketing.
Leading AI agency in Guwahati specializing in biological intelligence, generative AI, and regulatory systems for Asia's underrepresented populations.
An entrant is a company tagged HealthTech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 6 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.